Literature DB >> 15649101

Surgical management of obesity: a review of the evidence relating to the health benefits and risks.

Michael D Lara1, Shanu N Kothari, Harvey J Sugerman.   

Abstract

Obesity continues to plague our society in epidemic proportions. Surgery for morbid obesity is considered by many as the most effective therapy for this complex disorder. Today, multiple surgical procedures for the treatment of obesity are available. As with most procedures, there are benefits and risks associated with open and laparoscopic gastric bypass surgery, as well as with laparoscopic adjustable gastric banding and partial biliopancreatic bypass with a duodenal switch. The risks and complications associated with bariatric surgery may be serious and in some cases life threatening. However, surgery for obesity has shown remarkable results in helping patients to achieve significant long-term weight control. In addition, it is associated with improvement and often resolution of co-morbid conditions, including type 2 diabetes mellitus, systemic hypertension, obesity hypoventilation, sleep apnea, venous stasis disease, pseudotumor cerebri, polycystic ovary syndrome, complications of pregnancy and delivery, gastroesophageal reflux disease, stress urinary incontinence, degenerative joint disease, and non-alcoholic steatohepatitis.

Entities:  

Mesh:

Year:  2005        PMID: 15649101     DOI: 10.2165/00024677-200504010-00006

Source DB:  PubMed          Journal:  Treat Endocrinol        ISSN: 1175-6349


  19 in total

Review 1.  Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies.

Authors:  M Fried; G Ribaric; J N Buchwald; S Svacina; K Dolezalova; N Scopinaro
Journal:  Obes Surg       Date:  2010-06       Impact factor: 4.129

2.  The impact of race on weight loss after Roux-en-Y gastric bypass surgery.

Authors:  Glenn Harvin; Mark DeLegge; Donald A Garrow
Journal:  Obes Surg       Date:  2007-12-15       Impact factor: 4.129

3.  Modified jejunoileal bypass surgery with biliary diversion for morbid obesity and changes in liver histology during follow-up.

Authors:  Iraj Fazel; Akram Pourshams; Shahin Merat; Roya Hemayati; Masoud Sotoudeh; Reza Malekzadeh
Journal:  J Gastrointest Surg       Date:  2007-08       Impact factor: 3.452

Review 4.  The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012.

Authors:  Su-Hsin Chang; Carolyn R T Stoll; Jihyun Song; J Esteban Varela; Christopher J Eagon; Graham A Colditz
Journal:  JAMA Surg       Date:  2014-03       Impact factor: 14.766

5.  Optimizing outcomes in bariatric surgery: outpatient laparoscopic gastric bypass.

Authors:  Todd M McCarty; David T Arnold; Jeffrey P Lamont; Tammy L Fisher; Joseph A Kuhn
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

Review 6.  Obesity and pelvic floor disorders: a systematic review.

Authors:  W Jerod Greer; Holly E Richter; Alfred A Bartolucci; Kathryn L Burgio
Journal:  Obstet Gynecol       Date:  2008-08       Impact factor: 7.661

7.  Capacity for physical activity predicts weight loss after Roux-en-Y gastric bypass.

Authors:  Ida J Hatoum; Heather K Stein; Benjamin F Merrifield; Lee M Kaplan
Journal:  Obesity (Silver Spring)       Date:  2008-11-06       Impact factor: 5.002

8.  Histological esophagitis before and after surgical treatment of morbid obesity (Capella technique): a prospective study.

Authors:  Galzuinda Maria Figueiredo Reis; Paulo Roberto Savassi-Rocha; Ana Margarida M F Nogueira; Marcílio José Rodrigues Lima; Silas de Carvalho; Vitor Arantes; Carlos Alberto Barros; Omar Lopes Cançado
Journal:  Obes Surg       Date:  2008-02-22       Impact factor: 4.129

9.  Clinical pathway for laparoscopic gastric bypass.

Authors:  Maria Dolores Frutos; Juan Luján; Quiteria Hernández; Graciela Valero; Pascual Parrilla
Journal:  Obes Surg       Date:  2007-11-17       Impact factor: 4.129

10.  Bariatric surgery in the management of childhood obesity: should there be an age limit?

Authors:  Dilip Dan; Dave Harnanan; Shiva Seetahal; Vijay Naraynsingh; Surujpal Teelucksingh
Journal:  Obes Surg       Date:  2009-10-21       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.